Iron overload (with attention to genetic testing and diagnosis/management of HFE wild type patients)

被引：0

作者：

Siddaiah N. ^{[1
]}

Kowdley K.V. ^{[1
]}

机构：

[1] University of Washington Medical Center, Seattle, WA 98195

来源：

Current Treatment Options in Gastroenterology | 2006年 / 9卷 / 6期

关键词：

Iron Overload; Hemochromatosis; Serum Ferritin Level; Hereditary Hemochromatosis; Hepatic Iron;

D O I：

10.1007/s11938-006-0001-z

中图分类号：

学科分类号：

摘要：

The discovery of the HFE, HJV, HAMP, TfR2, and SLC40A1 genes and preliminary understanding of their roles in iron homeostasis have contributed tremendously to our understanding of the pathogenesis of genetic hemochromatosis. Although several new models of iron metabolism have been proposed, some key "sensor" steps of iron absorption in the enterocytes and of iron storage in hepatocytes and other cells remain unclear. A diagnosis of non-HFE genetic hemochromatosis should be considered in patients with unexplained iron overload who do not have the common mutations in the HFE genes. Phenotypic evaluation such as Liver biopsy and measurement of hepatic iron concentration remain important in non-HFE hemochromatosis because mutations in other genes are rare and there are no other available noninvasive tests to confirm the diagnosis. Phlebotomy remains the mainstay of therapy also for non-HFE hemochromatosis. However, phlebotomy may not be well tolerated in certain forms of non-HFE hemochromatosis such as "ferroportin disease." Copyright © 2006 by Current Science Inc.

引用

页码：447 / 455

页数：8

共 35 条

[1]

von Recklinghausen F.D., Hemochromatosis, Taggeblatt Versammlung Dtsch Naturforsch Arzte Heidelberg, 62, pp. 324-325, (1889)

[2]

Sheldon J., Haemochromatosis, (1935)

[3]

Simon M., Pawlotsky Y., Bourel M., Et al., Letter: Idiopathic hemochromatosis associated with HL-A 3 tissular antigen, Nouv Presse Med, 4, (1975)

[4]

Simon M., Le Mignon L., Fauchet R., Et al., A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association, Am J Hum Genet, 41, pp. 89-105, (1987)

[5]

Feder J.N., Gnirke A., Thomas W., Et al., A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis, Nat Genet, 13, pp. 399-408, (1996)

[6]

Piperno A., Sampietro M., Pietrangelo A., Et al., Heterogeneity of hemochromatosis in Italy, Gastroenterology, 114, pp. 996-1002, (1998)

[7]

Borot N., Roth M., Malfroy L., Et al., Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients, Immunogenetics, 45, pp. 320-324, (1997)

[8]

Lamon J.M., Marynick S.P., Roseblatt R., Donnelly S., Idiopathic hemochromatosis in a young female. A case study and review of the syndrome in young people, Gastroenterology, 76, pp. 178-183, (1979)

[9]

Roetto A., Papanikolaou G., Politou M., Et al., Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis, Nat Genet, 33, pp. 21-22, (2003)

[10]

Nemeth E., Tuttle M.S., Powelson J., Et al., Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, 306, pp. 2090-2093, (2004)

← 1 2 3 4 →